Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0001193125-26-027409

Options or other derivatives

  • Chief Medical Officer acquired 136,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nichols William Garrett Chief Medical Officer 2026-01-26 Grant or award · Stock Option (Right to Buy) +136,500 136,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…